BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1737762)

  • 1. Calcium and catecholamine interactions with adrenal chromogranins. Comparison of driving forces in binding and aggregation.
    Videen JS; Mezger MS; Chang YM; O'Connor DT
    J Biol Chem; 1992 Feb; 267(5):3066-73. PubMed ID: 1737762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH- and Ca(2+)-dependent aggregation property of secretory vesicle matrix proteins and the potential role of chromogranins A and B in secretory vesicle biogenesis.
    Yoo SH
    J Biol Chem; 1996 Jan; 271(3):1558-65. PubMed ID: 8576153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca2+ binding to chromaffin vesicle matrix proteins: effect of pH, Mg2+, and ionic strength.
    Reiffen FU; Gratzl M
    Biochemistry; 1986 Jul; 25(15):4402-6. PubMed ID: 3756146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble serotonin and catecholamine binding proteins in the bovine adrenal medulla.
    Pinxteren J; Jimenez del Rio M; Velez Pardo C; Ebinger G; Vauquelin G; De Potter W
    Neurochem Int; 1993 Oct; 23(4):343-50. PubMed ID: 8220176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of calcium with porcine adrenal chromogranin A (secretory protein-I) and chromogranin B (secretogranin I).
    Gorr SU; Shioi J; Cohn DV
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E247-54. PubMed ID: 2764102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-dependence of chromogranin A-catecholamine interaction.
    Westermann R; Stögbauer F; Unsicker K; Lietzke R
    FEBS Lett; 1988 Nov; 239(2):203-6. PubMed ID: 3181426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromogranins, widespread in endocrine and nervous tissue, bind Ca2+.
    Reiffen FU; Gratzl M
    FEBS Lett; 1986 Jan; 195(1-2):327-30. PubMed ID: 3943617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromogranin A: localization and stoichiometry in large dense core catecholamine storage vesicles from sympathetic nerve.
    O'Connor DT; Klein RL; Thureson-Klein AK; Barbosa JA
    Brain Res; 1991 Dec; 567(2):188-96. PubMed ID: 1817725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogranin A: posttranslational modifications in secretory granules.
    Barbosa JA; Gill BM; Takiyyuddin MA; O'Connor DT
    Endocrinology; 1991 Jan; 128(1):174-90. PubMed ID: 1986917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pH and Ca2+ on heterodimer and heterotetramer formation by chromogranin A and chromogranin B.
    Yoo SH; Lewis MS
    J Biol Chem; 1996 Jul; 271(29):17041-6. PubMed ID: 8663344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca2(+)-induced conformational change and aggregation of chromogranin A.
    Yoo SH; Albanesi JP
    J Biol Chem; 1990 Aug; 265(24):14414-21. PubMed ID: 2387861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of chromogranins A, B, and C from bovine chromaffin granules and a rat pheochromocytoma.
    Fischer-Colbrie R; Schober M
    J Neurochem; 1987 Jan; 48(1):262-70. PubMed ID: 3794705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the composition of chromaffin granules in adrenaline and noradrenaline containing cells of bovine adrenal medulla.
    Weiss C; Cahill AL; Laslop A; Fischer-Colbrie R; Perlman RL; Winkler H
    Neurosci Lett; 1996 Jun; 211(1):29-32. PubMed ID: 8809840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High capacity, low affinity Ca2+ binding of chromogranin A. Relationship between the pH-induced conformational change and Ca2+ binding property.
    Yoo SH; Albanesi JP
    J Biol Chem; 1991 Apr; 266(12):7740-5. PubMed ID: 2019597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human chromogranin A. Purification and characterization from catecholamine storage vesicles of human pheochromocytoma.
    O'Connor DT; Frigon RP; Sokoloff RL
    Hypertension; 1984; 6(1):2-12. PubMed ID: 6693145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biogenesis of chromaffin granules: incorporation of sulfate into chromogranin B and into a proteoglycan.
    Falkensammer G; Fischer-Colbrie R; Winkler H
    J Neurochem; 1985 Nov; 45(5):1475-80. PubMed ID: 4045458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and pH-dependent secretory vesicle membrane binding of chromogranin B.
    Yoo SH
    Biochemistry; 1995 Jul; 34(27):8680-6. PubMed ID: 7612608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence studies of nucleotide interactions with bovine adrenal chromogranin A.
    Yoo SH; Albanesi JP; Jameson DM
    Biochim Biophys Acta; 1990 Aug; 1040(1):66-70. PubMed ID: 2378903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromogranin B: isolation from pheochromocytoma, N-terminal sequence, tissue distribution and secretory vesicle processing.
    Gill BM; Barbosa JA; Dinh TQ; Garrod S; O'Connor DT
    Regul Pept; 1991 Apr; 33(2):223-35. PubMed ID: 1882087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stoichiometric carboxyl methylation of chromogranins from bovine adrenal medullary cells.
    Veeraragavan K; Coulombe R; Gagnon C
    Biochem Biophys Res Commun; 1988 Apr; 152(2):732-8. PubMed ID: 3365250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.